Search Tag: innovative CAR T-cell therapies

Executive Health Management

2022 02 Aug

CARsgen Therapeutics Holdings Limited a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that  Dr. Hua Jiang ("Dr. Jiang") has been appointed as Executive Director of the Company . Dr. Jiang has about 18 years of working experiences in the field of cancer biotherapy.  She...Read more